News

HPQ Silicon Achieves Milestone with First Battery Cell Shipments

HPQ Silicon Achieves Milestone with First Battery Cell Shipments

HPQ Silicon's Exciting Development in Battery Technology

HPQ Silicon Inc. (“HPQ”) is thrilled to announce that it has successfully completed and shipped its first industrial batches of high-performance lithium-ion battery cells. Manufactured using their innovative GEN3 silicon-based anode material, these initial cells, which come in the 18650 and 21700 formats under the HPQ ENDURA+ brand, are now on their way to Montreal. This achievement is a significant leap forward in HPQ's journey from experimental phases to engaging with the market.

Pioneering Steps Toward Market Engagement

This milestone follows a prior announcement whereby HPQ projected an impressive annual production capacity of up to 1.5 million cells. This figure is made possible through HPQ's collaboration with its partner, Novacium SAS, marking a crucial shift from pilot testing to commercial production. The manufactured cells will be utilized in discussions with various sectors such as mobility, electronics, defense, and telecommunications, which are all in search of energy-dense solutions compatible with current lithium-ion technology.

Quotes from Leadership

“These shipments illustrate our capability to progress rapidly from research and development to commercial readiness,” stated Bernard J. Tourillon, Chairman, President, and CEO of HPQ Silicon Inc. “We are now ready to present our batteries to customers, supported by authentic performance data and a clearly defined path toward large-scale production.”

Efficient Manufacturing for Market Readiness

The production of HPQ ENDURA+ batteries will be undertaken by an established, large-scale battery manufacturer, which allows for a seamless integration into high-throughput production lines. This strategy offers scalability and flexibility essential for timely market entry. It ensures that HPQ and Novacium can focus on enhancing their proprietary silicon-based anode materials while also utilizing proven manufacturing expertise.

Product Specifications and Innovation

HPQ is pleased to confirm that it has finalized product specification sheets for both the 18650 (4,000 mAh) and 21700 (6,000 mAh) battery formats. These specifications offer technical precision for interested clients. By utilizing GEN3 silicon-based anode technology, HPQ ENDURA+ batteries are designed to create up to 1,000 charge cycles. This provides a notable advantage over typical market options, as these batteries exhibit superior energy density, addressing the rising global demand for advanced lithium-ion cells.

Strategic Position in an Expanding Market

To provide context, current comparable 18650 cells available generally deliver lower energy density levels, situated between 2,500 and 3,500 mAh and featuring a cycle life of fewer than 500 cycles. Typically retailing from US$4.50 to US$8.00 per cell, HPQ is strategically positioned to offer superior alternatives within this well-established price bracket. As global demand for cylindrical cells grows within sectors such as mobility, consumer electronics, and energy storage, HPQ aims to capture a significant share of the North American market.

Warrants Extension Announcement

In related news, HPQ's Board of Directors has formally resolved to extend the exercise date for 2,107,318 outstanding share purchase warrants issued during a previous non-brokered private placement. These warrants now have a new exercise date set for November 23, 2027. It's noteworthy that none of these warrants have been exercised in the last six months, with the exercise price remaining consistent at $0.30.

About HPQ Silicon Inc.

HPQ Silicon Inc. is a pioneering technology company based in Quebec, listed on the TSX Venture Exchange under the ticker TSX-V: HPQ. The company specializes in advanced materials and critical process development. Collaborating closely with Novacium, HPQ is at the forefront of next-generation silicon-based anode materials for lithium-ion batteries and is also developing innovative clean-hydrogen and waste-to-energy technologies.

The company is committed to becoming a low-cost, zero-CO? producer of fumed silica and high-purity silicon, leveraging technical support from PyroGenesis Inc. This commitment not only highlights HPQ's forward-thinking approach but also positions it well within the expanding sectors of energy storage and clean technology, aligned with global ambitions for achieving net-zero emissions.

Frequently Asked Questions

What are HPQ ENDURA+ battery cells?

HPQ ENDURA+ battery cells are high-performance lithium-ion batteries developed using HPQ’s proprietary GEN3 silicon-based anode technology.

What capacities do the 18650 and 21700 formats offer?

The 18650 format offers 4,000 mAh, while the 21700 format provides 6,000 mAh, catering to various energy storage needs.

How does HPQ ensure the quality of its batteries?

HPQ collaborates with an established large-scale battery manufacturer, enabling controlled production processes and quality assurance.

What market needs do HPQ's batteries address?

HPQ's batteries meet the growing demand for energy-dense solutions applicable to mobility, electronics, defense, and telecommunications sectors.

What is the future outlook for HPQ Silicon?

With strong partnerships and innovative product development, HPQ Silicon is poised for growth in the advanced materials and energy storage market.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

WIN Expands Global Family Support to 124 Countries

Updated Category News Views 55

WIN's Ambitious Global Expansion In the ever-twisting labyrinth of corporate benefits, WIN is stepping up its game. We're talking an expansion that balloons past traditional fertility offerings into a global medley of support services covering every conceivable family and health scenario. It ain’t just about making babies anymore. When you're dealing with 124 countries,...

Continue Reading
Protalix Unveils Promising Gout Therapy Data at ACR 2026

Updated Category News Views 31

A Glimmer of Hope for Gout Sufferers Uncontrolled gout patients may soon see a light at the end of the tunnel. Protalix BioTherapeutics (NYSE American: PLX) just rolled out data at the ACR Convergence 2026, underscoring the potential of their drug candidate, PRX-115. This revelation is a big deal for those grappling with gout that just won't quit, constantly pelted by...

Continue Reading
Xiaomi's Smart Auto Factory Draws Global Media Praise

Updated Category News Views 202

Xiaomi Impresses Global Media in Beijing Factory Tour In the ever-changing world of NEVs (New Energy Vehicles), a tour of Xiaomi's smart auto factory in Beijing has made waves among global media folks. These scribes got an up-close look at Xiaomi's magic mix of tech and style on November 6, part of a grand media gathering. What's Under the Hood? Marcos Costa de Oliveira,...

Continue Reading
EICMA 2026: Groundbreaking Moves in Two-Wheel World

Updated Category News Views 71

Revving Up in Milan: A Record-Breaking EICMA If you're into two-wheelers as much as stocks, EICMA 2026 is where all the action is happening. They opened the door with a bang at Fiera Milano Rho, pulling off their biggest showcase yet. Ten halls packed to the brim, up from nine the previous year, creating buzz across the globe. Showcasing 765 exhibitors and 2,142 brands...

Continue Reading
New Leadership at Reactive Tech: Claudio Facchin Steps In

Updated Category News Views 154

Facchin Joins Reactive Technologies: Power Play or Predictable Move? Let me tell you, the energy sector ain’t for the faint-hearted—especially when you’re talking grid stability. Reactive Technologies just tossed an ace on the table, appointing Claudio Facchin as the new Board Chairman. If you've been around the block, you might recognize Facchin's name from his...

Continue Reading
Leatt Gears Up for Q3 Results Conference Call

Updated Category News Views 106

A good heads-up, folks, isn't just about keeping helmets snug—it’s about knowing when to cash in, especially when Leatt Corporation's got their Q3 results ready to drop. November 12 is the big day, so circle that on your calendars. They're rolling out the numbers before the market even gets its coffee, possibly nudging the ticker, OTCQB:LEAT, in a ripple you’ll want...

Continue Reading
Target Hospitality's Growth and Earnings Analysis Q3 2026

Updated Category News Views 64

Strategic Transformation: A Mixed Bag of Results In the raucous world of high-stakes business, folks, Target Hospitality Corp. (NASDAQ: TH) is making quite the noise. For Q3 2026, they trumpeted a juicy $129.1 million in revenue, which is a solid notch up by 30% from a year before. Yet, like a seasoned trader facing a knife-edge call, they're handling a bittersweet...

Continue Reading
Energenesis Tackles Space Anemia with ATP Boost

Updated Category News Views 47

Gearing Up for Space Medicine: Enter Energenesis With the cosmic frontier drawing investor eyes and day-to-day operations inching skyward, here comes Energenesis Biomedical (TWSE: 6657), poking its head into space medicine. This isn’t just another biotech firm looking to throw drugs at terrestrial problems. No, Energenesis shot its shot at TASTI 2026 with its...

Continue Reading
Veterinary Stories Transform Pet Care in New Docuseries

Updated Category News Views 132

Peeling Back the Scrubs: Hidden Heroes in Vet Medicine Everyone's all-hands-on-deck when it's your furball on the line, but how much do you really know about what happens in those vet offices? Finally, National Veterinary Associates (NVA) is unzipping that mystery with a no-bones-about-it docuseries, Advancing Veterinary Medicine: Our Stories, right out of Austin, Texas....

Continue Reading
Zabalafin Hydrogel: Promise in Treating Atopic Dermatitis

Updated Category News Views 55

Pioneering a New Path in Dermatology Treatment In the world of dermatology, finding a topical solution that tackles the full spectrum of atopic dermatitis (AD) is as rare as hens' teeth. But here's a twist—in a recent research paper gracing the Journal of Drugs in Dermatology, Alphyn Biologics sheds light on their unique contender, Zabalafin Hydrogel. This ain't your...

Continue Reading

Top 5 Most Recently Viewed Articles

Qatar Airways Reveals New Lounge and Terminal at JFK Airport

Updated Category News Views 254

Qatar Airways Expands Presence at JFK Airport Qatar Airways is set to enhance its operations at John F. Kennedy International Airport by moving to the New Terminal One, which promises a first-of-its-kind experience for travelers in the United States. This airline, renowned for its exceptional service, is preparing to introduce a dedicated lounge in 2026, significantly...

Continue Reading
Venture Global Faces Class Action Amid Legal Challenges

Updated Category News Views 227

Venture Global Faces Legal Action Venture Global, Inc. has recently been embroiled in a securities class action lawsuit filed in the Southern District of New York. The lawsuit pertains to all individuals or entities who acquired Venture's securities during its initial public offering around January 2025, seeking to recover damages under federal securities laws. Claims of...

Continue Reading
Join Aclaris Therapeutics' R&D Day on Immuno-Inflammatory Gaps

Updated Category News Views 151

Aclaris Therapeutics R&D Day Focused on Patient Needs Aclaris Therapeutics, Inc. (NASDAQ: ACRS), a biopharmaceutical organization based in Pennsylvania, is set to host its highly anticipated R&D Day. This event is dedicated to exploring the evolving landscape of immuno-inflammatory diseases and the innovative solutions that the company is developing. The R&D Day will take...

Continue Reading
Cloudelligent Achieves Sixth Ranking in Global MSP List

Updated Category News Views 137

Cloudelligent Celebrates Top Ranking in MSP 501 Cloudelligent, a prominent Managed Cloud Services provider, has reached an impressive milestone by being recognized as the sixth-ranked company on Channel Futures' prestigious MSP 501 list for the year. This distinction is not merely a testament to their robust performance; it underscores their relentless commitment to...

Continue Reading
Lithia Motors Sees Earnings Growth, Yet Shares Decline

Updated Category News Views 116

Lithia Motors Reports Strong Financial Performance Why are Lithia Motors, Inc.‘s shares slipping despite a substantial earnings beat and impressive profitability growth? As investors grapple with mixed signals from the company’s latest financial performance, the story behind the numbers holds the key to understanding market reactions. Lithia Motors shares are trading...

Continue Reading